Vanda Pharmaceuticals
VNDA
#8788
Rank
NZ$0.41 B
Marketcap
NZ$6.80
Share price
6.41%
Change (1 day)
-13.37%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2023 (TTM): NZ$0.44

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$8.25. In 2022 the company made an earnings per share (EPS) of NZ$0.21 a decrease over its 2021 EPS that were of NZ$1.07.

EPS history for Vanda Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$0.44105.91%
2022NZ$0.21-80%
2021NZ$1.0739.53%
2020NZ$0.77-80.18%
2019NZ$3.87334%
2018NZ$0.89-247.06%
2017NZ-$0.61-19.05%
2016NZ-$0.75-55.32%
2015NZ-$1.67-347.37%
2014NZ$0.68-156.72%
2013NZ-$1.19-31.63%
2012NZ-$1.75172.22%
2011NZ-$0.64-238.46%
2010NZ$0.46-119.7%
2009NZ-$2.35-31.61%
2008NZ-$3.44-31.32%
2007NZ-$5.01-99.27%
2006NZ-$690.3336045.14%
2005NZ-$1.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.91-244.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.35-213.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.99-766.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.77-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.05-197.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ-$7.82-5.18%๐Ÿ‡บ๐Ÿ‡ธ USA